Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Perrone

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Cancers|August 12, 2022
Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous CystadenocarcinomaFrancesca Zalfa, Maria Grazia Perrone, Savina Ferorelli, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Exosomes in Ovarian Cancer: Towards Precision OncologyMaria Grazia Perrone, Silvana Filieri, Amalia Azzariti, et al.
Journal of Medicinal Chemistry|May 9, 2013
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitorsPaola Vitale, Stefania Tacconelli, Maria Grazia Perrone, et al.
Frontiers in Pharmacology|April 4, 2022
Bisphosphonates Targeting Ion Channels and Musculoskeletal EffectsRosa Scala, Fatima Maqoud, Marina Antonacci, et al.
European Journal of Medicinal Chemistry|June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detectionAntonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Pharmacology|January 17, 2015
Selective cyclooxygenase-1 inhibition by p6 and gastrotoxicity: preliminary investigationMaria Grazia Perrone, Dario Domenico Lofrumento, Paola Vitale, et al.
European Journal of Medicinal Chemistry|October 17, 2017
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrierMaria Grazia Perrone, Paola Vitale, Savina Ferorelli, et al.
Bioorganic & Medicinal Chemistry|February 16, 2008
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulatorsNicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, et al.
Molecules (Basel, Switzerland)|July 29, 2023
<i>m</i>-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective ActivityDamiano Rocchi, Juan F González, Olmo Martín-Cámara, et al.
European Journal of Medicinal Chemistry|August 13, 2023
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversersLaura Braconi, Silvia Dei, Marialessandra Contino, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Cancers|August 12, 2022
Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous CystadenocarcinomaFrancesca Zalfa, Maria Grazia Perrone, Savina Ferorelli, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Exosomes in Ovarian Cancer: Towards Precision OncologyMaria Grazia Perrone, Silvana Filieri, Amalia Azzariti, et al.
Journal of Medicinal Chemistry|May 9, 2013
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitorsPaola Vitale, Stefania Tacconelli, Maria Grazia Perrone, et al.
Frontiers in Pharmacology|April 4, 2022
Bisphosphonates Targeting Ion Channels and Musculoskeletal EffectsRosa Scala, Fatima Maqoud, Marina Antonacci, et al.
European Journal of Medicinal Chemistry|June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detectionAntonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Pharmacology|January 17, 2015
Selective cyclooxygenase-1 inhibition by p6 and gastrotoxicity: preliminary investigationMaria Grazia Perrone, Dario Domenico Lofrumento, Paola Vitale, et al.
European Journal of Medicinal Chemistry|October 17, 2017
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrierMaria Grazia Perrone, Paola Vitale, Savina Ferorelli, et al.
Bioorganic & Medicinal Chemistry|February 16, 2008
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulatorsNicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, et al.
Molecules (Basel, Switzerland)|July 29, 2023
<i>m</i>-Terphenylamines, Acting as Selective COX-1 Inhibitors, Block Microglia Inflammatory Response and Exert Neuroprotective ActivityDamiano Rocchi, Juan F González, Olmo Martín-Cámara, et al.
European Journal of Medicinal Chemistry|August 13, 2023
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversersLaura Braconi, Silvia Dei, Marialessandra Contino, et al.
Pageof 11